Lanean...
SUN-179 Prolonged Hypoglycemia from Insulin Degludec
Prolonged Hypoglycemia from Insulin Degludec Background: Patients with type 2 diabetes treated with insulin degludec compared with insulin glargine had a reduced risk of overall symptomatic hypoglycemia (1). This is primarily due to former’s long half-life (25 hours) and lack of trough lev...
Gorde:
| Argitaratua izan da: | J Endocr Soc |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Endocrine Society
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6553236/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-179 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|